4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001181431-13-052544
CIK 0001325879operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:55 AM ET
Size
8.4 KB
Accession
0001181431-13-052544
Insider Transaction Report
Form 4
HA NGOC TUAN
DirectorChief Executive Officer
Transactions
- Other
Common Stock
2013-09-06−118,187→ 0 total(indirect: Held by GRAT) - Other
Common Stock
2013-09-06+118,187→ 519,068 total - Disposition to Issuer
Common Stock
2013-10-02−137,500→ 381,568 total
Footnotes (5)
- [F1]The increase of shares of directly held common stock was due to a distrubition from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 6, 2013.
- [F2]Includes 3094 shares acquired on June 28, 2013 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
- [F3]The decrease of shares of indirectly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 6, 2013.
- [F4]Shares were held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT.
- [F5]Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of two awards of restricted stock granted to the reporting person on January 31, 2012 and January 24, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:55 AM ET
- Size
- 8.4 KB